Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditions
(2025)
Journal Article
Stevenson, M., Nakafero, G., Williams, H. C., Card, T., Taal, M. W., Aithal, G. P., Fox, C. P., & Abhishek, A. (in press). Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditions. Rheumatology. https://academic.oup.com/rheumatology
Objectives: To assess the cost-effectiveness of extending the interval between monitoring blood-tests beyond three monthly intervals during established treatment of adults prescribed low-dose weekly methotrexate (≤ 25 mg/week), leflunomide, or sulfas... Read More about Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditions.